STOCK TITAN

Dyne Therapeutics to Present at Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Dyne Therapeutics announced management's participation in a fireside chat at the Jefferies Global Healthcare Conference on June 9, 2022, at 3:00 p.m. ET. This event will be held in New York, NY, and a live webcast will be accessible via the company’s website. Additionally, a replay will be available for 90 days post-event. Dyne Therapeutics focuses on developing life-transforming therapeutics for genetically driven muscle diseases using its proprietary FORCE™ platform.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., June 03, 2022 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference being held in New York, NY on Thursday, June 9, 2022 at 3:00 p.m. ET.

A live webcast will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days following the presentation.

About Dyne Therapeutics

Dyne Therapeutics is building a leading muscle disease company dedicated to advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue seen with other approaches. Dyne has a broad portfolio of programs for serious muscle diseases, including candidates for myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/, and follow us on TwitterLinkedIn and Facebook.

Contact:

Dyne Therapeutics
Amy Reilly
areilly@dyne-tx.com
857-341-1203


FAQ

What is Dyne Therapeutics' ticker symbol?

The ticker symbol for Dyne Therapeutics is DYN.

When is the Dyne Therapeutics fireside chat scheduled?

The fireside chat is scheduled for June 9, 2022, at 3:00 p.m. ET.

Where will the Jefferies Global Healthcare Conference be held?

The Jefferies Global Healthcare Conference will be held in New York, NY.

How can I watch the Dyne Therapeutics event?

The event can be watched live via the webcast on Dyne Therapeutics' website.

How long will the replay of the fireside chat be available?

The replay will be available for 90 days following the presentation.

Dyne Therapeutics, Inc.

NASDAQ:DYN

DYN Rankings

DYN Latest News

DYN Stock Data

3.02B
99.61M
0.49%
112.41%
9.9%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WALTHAM